|Mr. Santiago De Torres Sanahuja||Exec. Chairman||N/A||N/A||N/A|
|Ms. Isabel Lozano Fernandez||CEO & Exec. Director||N/A||N/A||N/A|
|Dr. Carlos Cordon-Cardo||Founder & Scientific VP||N/A||N/A||N/A|
|Dr. Zvi Fuchs||Founder and Medical VP||N/A||N/A||N/A|
|Mr. Jose Maria Huch Ginesta||Chief Financial Officer||N/A||N/A||N/A|
|Carlos Girón||Chief Technology Officer||N/A||N/A||N/A|
|Encarna Vega||Admin. Director||N/A||N/A||N/A|
|Ms. Maria Marin||Head of Investor Relations||N/A||N/A||N/A|
|Ms. Gabriela Camunas||Gen. Counsel||N/A||N/A||N/A|
|Helena Vidal-Folch||Head of Communication||N/A||N/A||N/A|
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. The company offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics; and diagnostic second opinion, test directory, and clinical trials and R&D services. It uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology. The company also provides radiotherapy; and develops therapeutic modalities and diagnostic tools. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.
Atrys Health, S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.